Health Care & Life Sciences » Pharmaceuticals | IPCA Laboratories Ltd.

IPCA Laboratories Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
764
1,248
1,755
1,494
2,199
Total Accounts Receivable
6,220
5,330
5,862
6,844
8,184
Inventories
8,581
9,350
8,420
8,884
8,875
Other Current Assets
458
212
182
196
196
Total Current Assets
16,023
16,140
16,219
17,418
19,455
Net Property, Plant & Equipment
14,466
19,557
20,400
19,824
18,999
Total Investments and Advances
112
712
283
245
198
Long-Term Note Receivable
84
156
704
505
626
Intangible Assets
719
1,119
1,074
1,024
1,306
Other Assets
699
440
237
579
572
Total Assets
32,170
38,219
39,474
40,174
41,901
ST Debt & Current Portion LT Debt
3,086
4,343
3,829
3,640
3,936
Accounts Payable
3,413
3,041
4,211
3,965
4,235
Income Tax Payable
453
505
43
227
185
Other Current Liabilities
981
1,155
1,617
1,727
1,721
Total Current Liabilities
7,933
9,044
9,700
9,559
10,076
Long-Term Debt
2,940
5,032
4,843
3,517
2,340
Provision for Risks & Charges
149
180
202
246
259
Deferred Taxes
1,471
1,743
1,565
1,705
1,580
Other Liabilities
13
40
16
16
16
Total Liabilities
12,574
16,135
16,882
15,622
15,015
Common Equity (Total)
19,597
22,084
22,592
24,553
26,886
Total Shareholders' Equity
19,597
22,084
22,592
24,553
26,886
Total Equity
19,597
22,084
22,592
24,553
26,886
Liabilities & Shareholders' Equity
32,170
38,219
39,474
40,174
41,901

About IPCA Laboratories

View Profile
Address
142-AB, Kandivli Industrial Estate
Mumbai Maharashtra 400067
India
Employees -
Website http://www.ipcalabs.com
Updated 09/14/2018
Ipca Laboratories Ltd. engages in the manufacture, research, and development of pharmaceutical products. It offers active pharmaceuical ingredients such as Atenolol, Chloroquine Phosphate, Furosemide, Hydroxychloroquine Sulphate, Metoprolol Succinate, Metoprolol Tartrate, and Pyrantel Salts. The company was founded on October 19, 1949 and is headquartered in Mumbai, India.